Ironwood Pharmaceuticals (IRWD) Shares Outstanding (2010 - 2026)

Ironwood Pharmaceuticals has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $164.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 1.73% year-over-year to $164.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $164.6 million (up 1.73% YoY) and the FY2025 annual result came in at $163.1 million, up 1.78% from the prior year.
• Shares Outstanding (Entity) advanced to $164.6 million in Q1 2026 per IRWD's latest filing, from $163.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $164.6 million in Q1 2026 and troughed at $153.2 million in Q2 2022.
• A 5-year average of $158.4 million and a median of $159.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) decreased 6.17% in 2022, then advanced 2.49% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $154.0 million in 2022, then climbed by 1.51% to $156.4 million in 2023, then increased by 2.46% to $160.2 million in 2024, then increased by 1.78% to $163.1 million in 2025, then gained by 0.95% to $164.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $164.6 million, $163.1 million, and $162.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.